CL2007003590A1 - Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt - Google Patents
Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transtInfo
- Publication number
- CL2007003590A1 CL2007003590A1 CL200703590A CL2007003590A CL2007003590A1 CL 2007003590 A1 CL2007003590 A1 CL 2007003590A1 CL 200703590 A CL200703590 A CL 200703590A CL 2007003590 A CL2007003590 A CL 2007003590A CL 2007003590 A1 CL2007003590 A1 CL 2007003590A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- vasomotric
- sulfamida
- transt
- aril
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86964406P | 2006-12-12 | 2006-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2007003590A1 true CL2007003590A1 (es) | 2008-02-29 |
Family
ID=39273293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200703590A CL2007003590A1 (es) | 2006-12-12 | 2007-12-11 | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20080194654A1 (es) |
| EP (1) | EP2061776A1 (es) |
| JP (1) | JP2010512401A (es) |
| KR (1) | KR20090087506A (es) |
| CN (1) | CN101600701A (es) |
| AR (1) | AR064318A1 (es) |
| AU (1) | AU2007333593A1 (es) |
| BR (1) | BRPI0720289A2 (es) |
| CA (1) | CA2671844A1 (es) |
| CL (1) | CL2007003590A1 (es) |
| CR (1) | CR10866A (es) |
| EC (1) | ECSP099411A (es) |
| MX (1) | MX2009006359A (es) |
| NO (1) | NO20092092L (es) |
| PE (1) | PE20081395A1 (es) |
| RU (1) | RU2009121017A (es) |
| SV (1) | SV2009003295A (es) |
| TW (1) | TW200843753A (es) |
| WO (1) | WO2008073459A1 (es) |
| ZA (1) | ZA200904109B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009076502A1 (en) * | 2007-12-12 | 2009-06-18 | Wyeth | Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
| GB0813694D0 (en) * | 2008-07-25 | 2008-09-03 | Glaxo Group Ltd | Compounds |
| WO2011109277A1 (en) * | 2010-03-04 | 2011-09-09 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mglur2 |
| CN102838567B (zh) * | 2011-06-23 | 2014-12-31 | 深圳市湘雅生物医药研究院 | 一种苯磺酰或苯甲酰哌嗪类化合物及其制备方法和用途 |
| CA2854836C (en) * | 2011-11-07 | 2020-10-27 | Emory University | Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| US9867813B2 (en) * | 2015-11-17 | 2018-01-16 | Thomas Daly | Aminopyridine based buffers with wide buffering ranges, antibiotics and myelin disease therapy |
| CN107337616A (zh) * | 2017-07-13 | 2017-11-10 | 上海昕盛医药科技有限公司 | 一种盐酸班布特罗杂质f的合成方法 |
| CN107445845A (zh) * | 2017-08-24 | 2017-12-08 | 重庆沃肯精细化工有限公司 | 一种合成氯法齐明关键中间体n‑(4‑氯苯基)‑1，2‑苯二胺的方法 |
| EP3810574A1 (en) * | 2018-06-21 | 2021-04-28 | Cellestia Biotech AG | Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts |
| CA3166630A1 (en) | 2020-01-03 | 2021-07-08 | Berg Llc | Polycyclic amides as ube2k modulators for treating cancer |
| CN116003261A (zh) * | 2022-12-19 | 2023-04-25 | 江苏康恒化工有限公司 | 新型聚氨酯扩链剂2-氨基-2’-氯二苯胺的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3177221A (en) * | 1963-02-05 | 1965-04-06 | Mcneilab Inc | 2, 1, 3-benzothiadiazoline-2, 2-dioxides |
| SK94393A3 (en) | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
| ZA966885B (en) * | 1995-08-22 | 1998-02-16 | Du Pont Merck Pharma | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| AU8645401A (en) * | 2000-08-14 | 2002-02-25 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
| JP4380992B2 (ja) * | 2001-04-18 | 2009-12-09 | ユーロ−セルティーク エス．エイ． | ノシセプチン類似体 |
| EP1466625A4 (en) * | 2001-12-28 | 2007-07-18 | Takeda Pharmaceutical | PREVENTIVE / HEALING MEDICINE FOR BLADDER DISORDER |
| US20080188478A1 (en) | 2005-04-26 | 2008-08-07 | Pfizer Inc. | Compounds Useful In Therapy |
| PE20070544A1 (es) | 2005-09-29 | 2007-07-26 | Wyeth Corp | Derivados de benzotiadiazolilfenilalquilamina |
-
2007
- 2007-12-11 CL CL200703590A patent/CL2007003590A1/es unknown
- 2007-12-12 BR BRPI0720289-0A patent/BRPI0720289A2/pt not_active Application Discontinuation
- 2007-12-12 KR KR1020097014272A patent/KR20090087506A/ko not_active Application Discontinuation
- 2007-12-12 CN CNA2007800500208A patent/CN101600701A/zh active Pending
- 2007-12-12 JP JP2009541360A patent/JP2010512401A/ja not_active Withdrawn
- 2007-12-12 US US11/955,204 patent/US20080194654A1/en not_active Abandoned
- 2007-12-12 EP EP07862811A patent/EP2061776A1/en not_active Withdrawn
- 2007-12-12 AU AU2007333593A patent/AU2007333593A1/en not_active Abandoned
- 2007-12-12 CA CA002671844A patent/CA2671844A1/en not_active Abandoned
- 2007-12-12 US US11/955,018 patent/US7601722B2/en not_active Expired - Fee Related
- 2007-12-12 RU RU2009121017/04A patent/RU2009121017A/ru not_active Application Discontinuation
- 2007-12-12 MX MX2009006359A patent/MX2009006359A/es not_active Application Discontinuation
- 2007-12-12 US US11/955,195 patent/US20080161366A1/en not_active Abandoned
- 2007-12-12 TW TW096147565A patent/TW200843753A/zh unknown
- 2007-12-12 PE PE2007001769A patent/PE20081395A1/es not_active Application Discontinuation
- 2007-12-12 WO PCT/US2007/025405 patent/WO2008073459A1/en active Application Filing
- 2007-12-12 AR ARP070105585A patent/AR064318A1/es unknown
-
2009
- 2009-05-29 NO NO20092092A patent/NO20092092L/no not_active Application Discontinuation
- 2009-06-11 SV SV2009003295A patent/SV2009003295A/es unknown
- 2009-06-11 ZA ZA200904109A patent/ZA200904109B/xx unknown
- 2009-06-12 CR CR10866A patent/CR10866A/es not_active Application Discontinuation
- 2009-06-12 EC EC2009009411A patent/ECSP099411A/es unknown
- 2009-08-27 US US12/548,844 patent/US20100029641A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010512401A (ja) | 2010-04-22 |
| MX2009006359A (es) | 2009-06-26 |
| ECSP099411A (es) | 2009-07-31 |
| US7601722B2 (en) | 2009-10-13 |
| TW200843753A (en) | 2008-11-16 |
| BRPI0720289A2 (pt) | 2014-02-04 |
| EP2061776A1 (en) | 2009-05-27 |
| NO20092092L (no) | 2009-08-19 |
| CN101600701A (zh) | 2009-12-09 |
| KR20090087506A (ko) | 2009-08-17 |
| AR064318A1 (es) | 2009-03-25 |
| US20100029641A1 (en) | 2010-02-04 |
| ZA200904109B (en) | 2010-04-28 |
| RU2009121017A (ru) | 2011-01-20 |
| CA2671844A1 (en) | 2008-06-19 |
| PE20081395A1 (es) | 2008-09-17 |
| US20080167303A1 (en) | 2008-07-10 |
| SV2009003295A (es) | 2009-10-29 |
| AU2007333593A1 (en) | 2008-06-19 |
| US20080194654A1 (en) | 2008-08-14 |
| CR10866A (es) | 2009-07-14 |
| US20080161366A1 (en) | 2008-07-03 |
| WO2008073459A1 (en) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2007003590A1 (es) | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt | |
| CL2007003591A1 (es) | Compuestos derivados de sulfonamida ciclicos, inhibidores de retoma de monoamina; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de disfuncion sexual, trastorno gastrointestinal, trastorno genitourinari | |
| IL219915A0 (en) | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases | |
| CL2007002972A1 (es) | Compuestos derivados de imidazolona e imidazolidinona, inhibidores de la 11b-hsd1; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para el tratamiento y prevencion de diabetes, obesidad, trastornos alimentarios, disl | |
| CL2007001882A1 (es) | Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos. | |
| CL2007001881A1 (es) | Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos. | |
| IL178730A0 (en) | New pharmaceutical compositions for the treatment of sexual disorders ii | |
| CL2008000066A1 (es) | Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem | |
| DK1928405T3 (da) | Farmaceutiske sammensætninger til behandling af indre øreforstyrrelser | |
| CL2008000703A1 (es) | Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos. | |
| IL199472A0 (en) | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms, processes for the preparation of the same and uses thereof | |
| CL2007002578A1 (es) | Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer. | |
| CL2007002641A1 (es) | Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias. | |
| CL2007002920A1 (es) | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. | |
| CL2008000065A1 (es) | Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia. | |
| CL2007002169A1 (es) | Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina | |
| CL2007003697A1 (es) | Compuestos derivados de sulfonamida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de la hiperglucemia, diabetes, obesidad, hipertension, hiperlipidemia, sindrome metabol | |
| CL2007001992A1 (es) | Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege | |
| CL2007002252A1 (es) | Compuestos derivados de heterociclos de nitrogeno fusionados; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, sarcopenia, caquexia, espasmos musculares, debilidad muscular despues de o | |
| EP1986639A4 (en) | PHARMACEUTICAL COMPOSITIONS OF DEXTROMETHORPHANE AND CHINIDINE FOR THE TREATMENT OF DEPRESSION, FEAR STATES AND NEURODEEGENERATIVE DISEASES | |
| CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
| EP2107909A4 (en) | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC DISORDERS | |
| EP2099449A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE | |
| ZA200606804B (en) | Pharmaceutical composition for treatment of immunological disorders | |
| CL2007003423A1 (es) | Compuestos derivados de pirimidinas sustituidas; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis reumatoidea, aterosclerosis, entre otras enfermeda |